Jefferies Financial Group’s Alnylam Pharmaceuticals ALNY Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$8.45M	Sell	25,553 -769	-3%	-$262K	0.1%	232
2025 Q4	$10.5M	Buy	26,322 +9,780	+59%	+$4.33M	0.09%	309
2025 Q3	$7.54M	Buy	16,542 +8,200	+98%	+$3.34M	0.07%	276
2025 Q2	$2.72M	Sell	8,342 -7,005	-46%	-$1.94M	0.04%	449
2025 Q1	$4.14M	Buy	+15,347	New	+$3.94M	0.07%	347
2024 Q4	–	Sell	-47,193	Closed	-$13M	–	1568
2024 Q3	$13M	Buy	47,193 +44,893	+1,952%	+$11.7M	0.21%	137
2024 Q2	$559K	Buy	2,300 +458	+25%	+$72.3K	0.01%	937
2024 Q1	$275K	Buy	1,842 +1,696	+1,162%	+$283K	0.01%	1245
2023 Q4	$27.9K	Sell	146 -4,632	-97%	-$789K	﹤0.01%	1607
2023 Q3	$846K	Sell	4,778 -5,129	-52%	-$979K	0.02%	882
2023 Q2	$1.88M	Buy	9,907 +5,367	+118%	+$1.06M	0.04%	677
2023 Q1	$909K	Sell	4,540 -6,171	-58%	-$1.3M	0.02%	928
2022 Q4	$2.55M	Buy	+10,711	New	+$2.28M	0.04%	573